Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 5Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Neurofibroma, Plexiform 2Triple Negative Breast Neoplasms 1Sarcoma, Kaposi 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Optic Nerve Glioma 1Neurofibrosarcoma 1Neoplasms 1Lung Neoplasms 1Liver Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Astrocytoma 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

Zoledronic Acid 2pegfilgrastim 1Samarium-153 1Samarium 1Radiotherapy 1Prednisone 1Pamidronate 1Lidocaine 1Ketamine 1Genistein 1Filgrastim 1Fentanyl 1Extracorporeal Shockwave Therapy 1Docetaxel 1D-methadone 1Azacitidine 1Antibodies, Monoclonal 1Amantadine 1AZD 6244 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Pain × AZD 6244 × Clear all
NCT01362803 2026-06-01

AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Active not recruiting
99 enrolled 1 FDA
CNS

Neurofibromatosis 1, Pain, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡